VRTX FCF Yield: current value, 10-year range and year-by-year history
Cash & Leverage
VRTX's fcf yield is right around its 10-year median of 2.9%.
FCF Yield History
VRTX FCF Yield by year
Yearly range of VRTX’s fcf yield from 2016 to 2026. Over the full period it ranged from -1.3% to 6.2%, averaging 2.7%.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 2.5% | 3.0% | 3.4% | 2.9% |
| 2025 | -1.2% | 1.2% | 3.7% | 2.8% |
| 2024 | -1.3% | 1.0% | 3.5% | -0.9% |
| 2023 | 3.9% | 4.5% | 5.3% | 4.0% |
| 2022 | 3.3% | 4.4% | 5.4% | 5.1% |
| 2021 | 3.3% | 4.5% | 6.2% | 4.3% |
| 2020 | 2.3% | 3.5% | 5.5% | 4.8% |
| 2019 | 2.3% | 2.7% | 3.3% | 2.6% |
| 2018 | 1.6% | 1.9% | 2.7% | 2.7% |
| 2017 | 0.7% | 1.5% | 2.0% | 1.8% |
| 2016 | -0.3% | 0.2% | 0.4% | 0.4% |
Free cash flow generated divided by market capitalisation. Often more reliable than earnings yield because it reflects actual cash — harder to inflate through accounting choices.
Free Cash Flow / Market Cap × 100%Think of it as the "cash earnings yield" on your investment. High FCF yield vs history suggests the market may be undervaluing the company's real cash generation ability.
- FCF can be lumpy year-to-year due to irregular capex or working capital swings. Look at 3–5 year trends, not single-year readings.
- Businesses intentionally reinvesting for growth will show low or negative FCF yield by design — this metric is less useful for high-growth phase companies.
Is VRTX FCF Yield High or Low Right Now?
Vertex Pharmaceuticals Incorporated's FCF Yield is currently 2.9%, which is around average relative to its 10-year historical range. The 10-year median FCF Yield for VRTX is approximately 2.9%. See all VRTX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.